Regenxbio
RGNX----
Regenxbio (RGNX)
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Regenxbio Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$24.27149.08%
Forecast & RatingBuy
11analysts
- Strong buy54.55%
- Buy36.36%
- Hold9.09%
- Sell0.00%
- Strong sell0.00%
News
- PR Newswire · 2 days ago, 06:29 PM
Kuehn Law Encourages Investors of Regenxbio, Inc. to Contact Law Firm
- benzinga_article · Jul 21 at 02:52 PM
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
- Price Alert · Jul 20 at 02:12 PM
U.S. stock market midday update: Regenxbio up 8.90%, long-term effectiveness of gene therapy drives positive sentiment
- Market Beat · Jul 20 at 01:20 PM
REGENXBIO (NASDAQ:RGNX) Shares Up 8% - Should You Buy?
- benzinga_article · Jul 20 at 09:45 AM
Clinical Trial Results Show Extended Benefits for REGENXBIO Retinal Treatments
- Tip Ranks · Jul 20 at 06:58 AM
RegenXBio Raises Capital Through Public Equity Offering
